Physician
Pravinchandra P. Patel, MD P.C.
Pravinchandra P. Patel, MD P.C. was paid $2.21M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 47% of everything it billed.
33Billing provider infoPRAVINCHANDRA P. PATEL, MD P.C.
COLDWATER, MS 38618
COLDWATER, MS 38618
33aNPI1457527475assigned 04/30/2008
33bProvider typeFamily Medicine Physician
28Total paid$2.21M
24GClaims235,689
24DCodes billed112
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Mississippi
Rank by total paid#17 of 306
Median peer was paid$59K
This provider vs. median37×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,695 | $366K | |
| 2019 | 18,074 | $377K | |
| 2020 | 16,885 | $331K | |
| 2021 | 59,751 | $418K | |
| 2022 | 62,436 | $293K | |
| 2023 | 30,978 | $237K | |
| 2024incomplete | 29,870 | $185K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 47% | 31,530 | 24,957 | $1.04M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 24,236 | 18,878 | $711K |
| 94760 | 4.0% | 30,854 | 21,303 | $87K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.1% | 1,268 | 958 | $68K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.1% | 8,334 | 6,487 | $47K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 9,097 | 7,846 | $26K |
| 94681 | <1% | 826 | 804 | $18K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,754 | 1,656 | $15K |
| 20610 | <1% | 1,518 | 1,114 | $14K | |
| 94375 | <1% | 816 | 793 | $13K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 173 | 141 | $11K |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,565 | 10,712 | $11K |
100 more codes
| 81000 | <1% | 7,875 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,634 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,256 | $10K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 186 | $10K |
| 94200 | <1% | 826 | $9K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 846 | $8K |
| 86403 | <1% | 856 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 436 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 642 | $6K |
| 80305 | <1% | 2,449 | $6K | |
| 90686 | <1% | 1,315 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 315 | $6K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 857 | $6K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 344 | $5K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,286 | $4K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,760 | $4K |
| 99407 | <1% | 680 | $4K | |
| 76770 | <1% | 69 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,517 | $3K |
| 1125F | <1% | 15,660 | $2K | |
| 90674 | <1% | 176 | $2K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 21 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 20 | $1K |
| 3075F | <1% | 5,548 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,391 | $1K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 28 | $1K |
| 93000 | <1% | 177 | $1K | |
| 87400 | <1% | 98 | $984.07 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 12 | $802.64 |
| 90756 | <1% | 69 | $752.07 | |
| 72100 | <1% | 39 | $701.25 | |
| 3074F | <1% | 11,257 | $652.75 | |
| 94664 | <1% | 99 | $613.25 | |
| 76536 | <1% | 12 | $571.74 | |
| 99354 | <1% | 14 | $469.64 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 719 | $445.13 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 34 | $384.80 |
| 73560 | <1% | 25 | $361.91 | |
| 99406 | <1% | 91 | $353.77 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 330 | $260.45 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 1,557 | $230.62 |
| 83880 | <1% | 18 | $211.98 | |
| 99497 | <1% | 333 | $211.62 | |
| 96127 | <1% | 178 | $197.87 | |
| 3077F | <1% | 6,355 | $189.43 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 234 | $153.57 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | <1% | 590 | $146.80 |
| 85610 | <1% | 273 | $126.62 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 163 | $104.00 |
| 3044F | <1% | 1,017 | $71.22 | |
| 99080 | <1% | 365 | $69.68 | |
| 84484 | <1% | 18 | $67.32 | |
| 85379 | <1% | 18 | $61.08 | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,039 | $55.03 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 41 | $46.20 |
| 3078F | <1% | 9,896 | $43.74 | |
| 90656 | <1% | 12 | $33.44 | |
| 94761 | <1% | 18 | $32.42 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 274 | $26.97 |
| 3079F | <1% | 10,619 | $24.07 | |
| 82553 | <1% | 18 | $23.10 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 1,980 | $19.30 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 93 | $9.48 |
| 96160 | <1% | 40 | $8.28 | |
| G9744 | Patient not eligible due to active diagnosis of hypertension | 0% | 24 | $0.00 |
| 1159F | 0% | 80 | $0.00 | |
| 3045F | 0% | 14 | $0.00 | |
| 3288F | 0% | 267 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 811 | $0.00 |
| 1160F | 0% | 68 | $0.00 | |
| 1124F | 0% | 27 | $0.00 | |
| G9991 | Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period | 0% | 33 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 39 | $0.00 |
| 4040F | 0% | 142 | $0.00 | |
| 4013F | 0% | 285 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 29 | $0.00 |
| 1100F | 0% | 32 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 29 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 41 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 33 | $0.00 |
| 0521F | 0% | 34 | $0.00 | |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 0% | 18 | $0.00 |
| 99442 | 0% | 44 | $0.00 | |
| 3080F | 0% | 2,446 | $0.00 | |
| 3017F | 0% | 114 | $0.00 | |
| 1170F | 0% | 422 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 67 | $0.00 |
| 1123F | 0% | 188 | $0.00 | |
| 99000 | 0% | 267 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 61 | $0.00 |
| 4010F | 0% | 213 | $0.00 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 205 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 93 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 35 | $0.00 |
| 1111F | 0% | 113 | $0.00 | |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 117 | $0.00 |
| 1126F | 0% | 82 | $0.00 | |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 0% | 49 | $0.00 |
| 1006F | 0% | 63 | $0.00 | |
| 3008F | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPATEL, PRAVINCHANDRA (DR.)